OpenAI Foundation Pledges $25 Billion as It Funds Health and Life Sciences Research

The OpenAI Foundation, the philanthropic arm of the artificial intelligence company, is on track to become one of the wealthiest nonprofit organizations in the world. It holds a 26% stake in OpenAI, which is seeking a valuation of about $1.4 trillion, and could ultimately become the richest company. Established in October 2025 after a major upheaval in OpenAI’s governance and structure, the foundation has pledged to donate at least $25 billion.

The foundation has begun distributing grants as part of a $125 million commitment to create freely available data for health and life-sciences research. The latest awards include $40 million for a cancer-vaccine development project at the University of North Carolina at Chapel Hill, $500,000 for a pilot project exploring how to reuse data from bankrupt biotechnology companies and $15 million for research aimed at better predicting how drugs cross the blood–brain barrier and other membranes.

These grants follow a $100 million award for Alzheimer’s disease research. Jacob Trefethen, director of life sciences at the OpenAI Foundation in San Francisco, California, previously worked at the billionaire-funded foundation Coefficient Giving. He told Nature that this is only the beginning and that the foundation plans to move quickly.

Why is the OpenAI Foundation funding health and life sciences?

“Our mission is to ensure that AI benefits all humanity,” Trefethen says. “One of the reasons we’re starting with life sciences and health is because we think that’s one of the areas where AI can benefit the most.”

Does the OpenAI Foundation share the goal of curing all diseases?

The Chan Zuckerberg Initiative announced in 2016 that it aims to cure all diseases by the end of the century. The OpenAI Foundation says it will also be ambitious, beginning with three areas of life sciences.

Public health data

For the foundation, public health data includes information related to any disease that causes more than 500,000 deaths worldwide each year, or to a similarly large-scale health disaster.

For example, the foundation wants to explore new possibilities for people who currently have insufficient treatment options for tuberculosis, the leading cause of death from infection. Trefethen says the foundation has a unifying philosophy and a desire to move quickly.

How could biological data accelerate medical research?

The foundation believes that combining greater intelligence with observations of more of the world could lead to breakthroughs against disease. Those observations generate scientific data.

For conditions such as Alzheimer’s disease, researchers do not yet know enough to develop better treatments for patients. The foundation therefore expects that progress will require more data in different formats. It wants to support the underlying scientific infrastructure so that researchers can build on shared resources and patients can benefit.

Could OpenAI benefit from the data generated by its grants?